Literature DB >> 30786056

Smoking and amyotrophic lateral sclerosis: A mendelian randomization study.

Yiqiang Zhan1, Fang Fang1.   

Abstract

In this study, we examined the potential causal effect of smoking on amyotrophic lateral sclerosis (ALS) using the Project MinE data involving 12,577 patients with ALS and 23,475 controls in a Mendelian randomization (MR) framework. The MR approach has the potential to investigate a causal relationship between a risk factor and a disease, avoiding confounding and information bias that often present in conventional epidemiological studies. We found that smokers had a higher risk of ALS compared to never smokers. Our study thus provides evidence for a causal relationship between smoking and ALS. Ann Neurol 2019;85:482-484.
© 2019 American Neurological Association.

Entities:  

Mesh:

Year:  2019        PMID: 30786056     DOI: 10.1002/ana.25443

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.

Authors:  Mengmeng Wang; Dandan Liu; Zhizhong Zhang; Wei Xie; Liping Cao; Linfeng Zhu; Meng Liu; Shiying Sheng; Xuegan Lian
Journal:  Mol Neurobiol       Date:  2021-02-08       Impact factor: 5.590

Review 2.  A review of Mendelian randomization in amyotrophic lateral sclerosis.

Authors:  Thomas H Julian; Sarah Boddy; Mahjabin Islam; Julian Kurz; Katherine J Whittaker; Tobias Moll; Calum Harvey; Sai Zhang; Michael P Snyder; Christopher McDermott; Johnathan Cooper-Knock; Pamela J Shaw
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

Review 3.  Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies.

Authors:  Marijne Vandebergh; Nicolas Degryse; Bénédicte Dubois; An Goris
Journal:  J Neurol       Date:  2022-04-02       Impact factor: 6.682

4.  Role of cigarette smoking in the development of ischemic stroke and its subtypes: a Mendelian randomization study.

Authors:  Yu Qian; Ding Ye; David Jh Wu; Chen Feng; Zhen Zeng; Lihong Ye; Rui Zhu; Zhenyu Zhang; Yingying Mao
Journal:  Clin Epidemiol       Date:  2019-08-13       Impact factor: 4.790

Review 5.  Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

Authors:  Ivana Štětkářová; Edvard Ehler
Journal:  Diagnostics (Basel)       Date:  2021-02-03

Review 6.  Epidemiology of amyotrophic lateral sclerosis: an update of recent literature.

Authors:  Elisa Longinetti; Fang Fang
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

7.  Smoking and multiple sclerosis risk: a Mendelian randomization study.

Authors:  Marijne Vandebergh; An Goris
Journal:  J Neurol       Date:  2020-06-11       Impact factor: 4.849

8.  No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population.

Authors:  Jéssica Barletto de Sousa Barros; Kamilla de Faria Santos; Rômulo Morais Azevedo; Rayana Pereira Dantas de Oliveira; Ana Carolina Dourado Leobas; Dhiogo da Cruz Pereira Bento; Rodrigo da Silva Santos; Angela Adamski da Silva Reis
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

9.  Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.

Authors:  Yixin Gao; Ting Wang; Xinghao Yu; Huashuo Zhao; Ping Zeng
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

10.  Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation.

Authors:  Yanlong Liu; Hui Li; Jian Wang; Qing Xue; Xiaoyu Yang; Yimin Kang; Mengjie Li; Jinzhong Xu; Guohua Li; Cunbao Li; Hui-Chih Chang; Kuan-Pin Su; Fan Wang
Journal:  JAMA Netw Open       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.